Prestige Consumer Healthcare Inc. (PBH)

US — Healthcare Sector
Peers: EVO  SUPN  COLL  DCPH  EGRX  SSIC  RGC  AMPH  PCRX  ANIP  PAHC  DLTNF  RAMMF  CVGRF  BHHKF  SPBBF 

Automate Your Wheel Strategy on PBH

With Tiblio's Option Bot, you can configure your own wheel strategy including PBH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol PBH
  • Rev/Share 22.894
  • Book/Share 36.9217
  • PB 2.2743
  • Debt/Equity 0.0283
  • CurrentRatio 4.2048
  • ROIC 0.077

 

  • MktCap 4149352359.0
  • FreeCF/Share 4.8955
  • PFCF 17.0551
  • PE 19.4453
  • Debt/Assets 0.0153
  • DivYield 0
  • ROE 0.122

 

  • Rating A-
  • Score 4
  • Recommendation Buy
  • P/E Score 2
  • DCF Score 5
  • P/B Score 2
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade PBH Sidoti Buy Neutral -- $90 Dec. 9, 2024

News

Should You Continue to Hold Prestige Consumer Stock in Your Portfolio?
PBH
Published: June 11, 2025 by: Zacks Investment Research
Sentiment: Neutral

PBH rides strong on e-commerce gains and brand innovations, but debt load and forex risks cast a shadow on future growth.

Read More
image for news Should You Continue to Hold Prestige Consumer Stock in Your Portfolio?
PBH vs. SYK: Which Stock Is the Better Value Option?
PBH, SYK
Published: May 30, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?

Read More
image for news PBH vs. SYK: Which Stock Is the Better Value Option?
Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock?
PBH
Published: May 27, 2025 by: Zacks Investment Research
Sentiment: Positive

PBH stock jumps on the back of brand strength, e-commerce gains and smart acquisitions despite tariff and foreign exchange headwinds.

Read More
image for news Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock?
PBH vs. ESLOY: Which Stock Should Value Investors Buy Now?
ESLOY, PBH
Published: May 14, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks presents investors with the better value opportunity right now?

Read More
image for news PBH vs. ESLOY: Which Stock Should Value Investors Buy Now?
Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates
PBH
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.30 per share. This compares to earnings of $1.02 per share a year ago.

Read More
image for news Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
PBH
Published: May 08, 2025 by: GlobeNewsWire
Sentiment: Neutral

TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025.

Read More
image for news UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
PBH
Published: May 08, 2025 by: GlobeNewsWire
Sentiment: Neutral

TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025.

Read More
image for news Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
PBH or ABT: Which Is the Better Value Stock Right Now?
ABT, PBH
Published: April 28, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?

Read More
image for news PBH or ABT: Which Is the Better Value Stock Right Now?
3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes
COR, HIMS, PBH
Published: April 17, 2025 by: Zacks Investment Research
Sentiment: Positive

Here, we discuss three medical device stocks ,COR, HIMS and PBH, that offer cheap valuations, making them attractive bets amid tariff risks.

Read More
image for news 3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes
PBH vs. SYK: Which Stock Is the Better Value Option?
PBH, SYK
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?

Read More
image for news PBH vs. SYK: Which Stock Is the Better Value Option?
PBH or BSX: Which Is the Better Value Stock Right Now?
BSX, PBH
Published: February 17, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?

Read More
image for news PBH or BSX: Which Is the Better Value Stock Right Now?

About Prestige Consumer Healthcare Inc. (PBH)

  • IPO Date 2005-02-10
  • Website https://www.prestigebrands.com
  • Industry Medical - Distribution
  • CEO Ms. Christine Sacco CPA
  • Employees 600

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.